Rocket Pharmaceuticals
RCKT
#5915
Rank
A$1.22 B
Marketcap
$11.49
Share price
3.01%
Change (1 day)
-68.51%
Change (1 year)

Earnings for Rocket Pharmaceuticals (RCKT)

Earnings in 2024 (TTM): -A$0.4 Billion

According to Rocket Pharmaceuticals 's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -A$0.39 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rocket Pharmaceuticals from 2014 to 2024

Annual earnings

Year Earnings Change
2024 -A$0.41 Billion5.35%
2023 -A$0.39 Billion10.7%
2022 -A$0.35 Billion31.23%
2021 -A$0.27 Billion21.02%
2020 -A$0.22 Billion80.79%
2019 -A$0.13 Billion3.69%
2018 -A$0.12 Billion323.4%
2017 -A$27.49 Million-58.93%
2016 -A$66.94 Million-36.96%
2015 -A$0.11 Billion613.27%
2014 -A$14.89 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.23 Billion-44.77%๐Ÿ‡บ๐Ÿ‡ธ USA